KLRK1 and melanoma: This suggests that the NKG2D-NKG2DL and DNAM-1-DNAM-1L axes play an important role in NK cell activation against melanoma, which is supported by the results of cytotoxicity blocking assays using antibodies inhibiting these receptor-ligand interactions [82].